Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma
- Daniel Keizman
- , Maya Ish-Shalom
- , Roberto Pili
- , Hans-Joerg Hammers
- , Mario A. Eisenberger
- , Victoria Sinibaldi
- , Ben Boursi
- , Natalie Maimon
- , Maya Gottfried
- , Henry Hayat
- , Avivit Peer
- , Svetlana Kovel
- , Avishay Sella
- , Raanan Berger
- , Michael A. Carducci
Research output: Contribution to journal › Article › peer-review
46
Link opens in a new tab
Scopus
citations